Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Timothy Ashby

Concepts (200)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
40
2025
3049
2.850
Why?
High-Throughput Nucleotide Sequencing
7
2022
182
1.140
Why?
Genomics
10
2023
268
0.860
Why?
Mutation
14
2022
1347
0.830
Why?
Software
4
2021
280
0.830
Why?
Plasma Cells
7
2025
239
0.760
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2025
125
0.650
Why?
Tumor Microenvironment
4
2024
256
0.590
Why?
Clonal Evolution
4
2020
58
0.560
Why?
Computational Biology
4
2020
212
0.530
Why?
Gene Expression Regulation, Neoplastic
6
2024
857
0.510
Why?
Algorithms
4
2020
672
0.480
Why?
Neoplasm Recurrence, Local
5
2024
649
0.450
Why?
Prognosis
13
2025
2099
0.400
Why?
Humans
48
2025
52483
0.400
Why?
Translocation, Genetic
7
2022
265
0.390
Why?
Gene Expression Profiling
10
2025
1105
0.390
Why?
Neoplasms
2
2020
1325
0.380
Why?
Positron-Emission Tomography
3
2025
301
0.380
Why?
Osteolysis
2
2022
75
0.370
Why?
Models, Molecular
1
2013
348
0.370
Why?
Hematopoietic Stem Cell Transplantation
3
2024
603
0.370
Why?
Diffusion Magnetic Resonance Imaging
2
2025
133
0.370
Why?
Chromosome Aberrations
3
2023
297
0.350
Why?
Genome, Human
3
2021
121
0.350
Why?
Evolution, Molecular
2
2021
93
0.350
Why?
Osteocytes
2
2024
226
0.340
Why?
Signal Transduction
4
2024
1671
0.340
Why?
Proteins
1
2013
348
0.330
Why?
Bone Marrow
3
2020
364
0.310
Why?
Epigenomics
2
2021
75
0.300
Why?
Disease Progression
8
2025
871
0.280
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1031
0.260
Why?
RANK Ligand
2
2024
187
0.250
Why?
Gene Rearrangement
2
2023
75
0.230
Why?
Oncogenes
3
2021
60
0.230
Why?
Chemokine CCL3
1
2024
13
0.230
Why?
HMGB1 Protein
1
2024
21
0.230
Why?
Chemokine CXCL12
1
2024
32
0.220
Why?
Bone Resorption
2
2024
302
0.210
Why?
Burkitt Lymphoma
1
2023
27
0.200
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
11
0.200
Why?
Gene Dosage
2
2020
78
0.200
Why?
Neoplasm, Residual
2
2025
173
0.200
Why?
Proto-Oncogene Proteins c-akt
1
2023
169
0.200
Why?
Epigenesis, Genetic
3
2023
406
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
81
0.190
Why?
Drug Resistance, Neoplasm
1
2024
326
0.190
Why?
Neoplasm Proteins
2
2021
334
0.190
Why?
Cell Communication
1
2022
71
0.190
Why?
Mice
8
2024
5949
0.180
Why?
Telomere Homeostasis
1
2021
11
0.180
Why?
Polycomb Repressive Complex 2
1
2021
48
0.180
Why?
Ubiquitination
1
2021
47
0.180
Why?
Transcriptome
3
2025
370
0.180
Why?
Chromosome Deletion
2
2023
142
0.180
Why?
Loss of Heterozygosity
2
2018
78
0.180
Why?
Lymphoma, B-Cell
1
2021
61
0.180
Why?
Genes, Tumor Suppressor
2
2021
74
0.170
Why?
Sequence Analysis, DNA
2
2018
229
0.170
Why?
Cell Cycle
1
2021
230
0.170
Why?
Cell Cycle Proteins
1
2021
169
0.170
Why?
B-Lymphocytes
1
2021
184
0.170
Why?
Lymphoma, Follicular
1
2020
27
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Female
13
2025
28171
0.160
Why?
Cell Line, Tumor
4
2024
1470
0.160
Why?
Aged
10
2025
10121
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Genes, myc
1
2019
39
0.160
Why?
Middle Aged
10
2025
13028
0.150
Why?
Aged, 80 and over
6
2025
3392
0.150
Why?
Tumor Suppressor Protein p53
2
2017
221
0.150
Why?
Mutagenesis
1
2018
61
0.150
Why?
Transplantation, Autologous
4
2024
488
0.150
Why?
Genome
1
2018
62
0.140
Why?
Homologous Recombination
1
2018
41
0.140
Why?
Male
13
2025
26761
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.140
Why?
Survival Rate
4
2021
945
0.130
Why?
Animals
8
2024
13505
0.130
Why?
DNA Repair
1
2018
195
0.130
Why?
Flow Cytometry
1
2018
478
0.130
Why?
DNA Copy Number Variations
3
2022
117
0.120
Why?
Adult
8
2025
14161
0.120
Why?
Remission Induction
3
2021
218
0.120
Why?
Genes, Neoplasm
1
2015
31
0.120
Why?
Pattern Recognition, Automated
1
2015
40
0.120
Why?
Cluster Analysis
1
2015
233
0.110
Why?
Follow-Up Studies
4
2021
2279
0.110
Why?
Databases, Protein
1
2013
28
0.100
Why?
Protein Structure, Secondary
1
2013
71
0.100
Why?
Sequence Alignment
1
2013
125
0.100
Why?
Amino Acid Sequence
1
2013
578
0.090
Why?
Chromatin
2
2023
139
0.090
Why?
T-Lymphocytes
2
2024
340
0.090
Why?
Breast Neoplasms
1
2020
1212
0.090
Why?
Adenocarcinoma
1
2015
405
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
263
0.090
Why?
Tumor Burden
2
2020
136
0.080
Why?
Alleles
2
2021
276
0.080
Why?
Clone Cells
2
2021
77
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
69
0.080
Why?
Histones
2
2021
314
0.080
Why?
DNA, Neoplasm
2
2020
146
0.080
Why?
DNA Mutational Analysis
2
2020
180
0.080
Why?
Lung Neoplasms
1
2015
636
0.080
Why?
Treatment Outcome
4
2020
5422
0.070
Why?
DNA Methylation
2
2023
592
0.070
Why?
Recurrence
2
2021
672
0.070
Why?
Genomic Instability
2
2018
89
0.070
Why?
Risk Factors
3
2021
3889
0.060
Why?
Cell Proliferation
2
2021
1023
0.060
Why?
ROC Curve
1
2025
253
0.060
Why?
Internet
2
2018
263
0.060
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
116
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
Why?
Xenograft Model Antitumor Assays
1
2024
220
0.050
Why?
Antibodies
1
2024
159
0.050
Why?
Proteasome Inhibitors
1
2024
104
0.050
Why?
Integrin beta Chains
1
2023
14
0.050
Why?
Integrins
1
2023
31
0.050
Why?
Oxidative Phosphorylation
1
2023
46
0.050
Why?
Cytogenetic Analysis
1
2023
80
0.050
Why?
B-Cell Maturation Antigen
1
2024
98
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cystatin M
1
2022
19
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
96
0.050
Why?
Immunoglobulins
1
2023
76
0.050
Why?
Forkhead Transcription Factors
1
2023
116
0.050
Why?
Retrospective Studies
2
2025
6607
0.050
Why?
Phylogeny
1
2022
231
0.050
Why?
Syndecan-1
1
2021
74
0.050
Why?
Spliceosomes
1
2021
10
0.050
Why?
Transcriptional Activation
1
2021
122
0.040
Why?
RNA Splicing
1
2021
41
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Alternative Splicing
1
2021
62
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Phosphoproteins
1
2021
119
0.040
Why?
Ecosystem
1
2021
96
0.040
Why?
Mice, Transgenic
1
2021
552
0.040
Why?
Single-Cell Analysis
1
2020
81
0.040
Why?
Cell Differentiation
1
2022
665
0.040
Why?
DNA
1
2023
549
0.040
Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
Why?
Melphalan
1
2020
181
0.040
Why?
Neoplasm Invasiveness
1
2020
278
0.040
Why?
Genetic Variation
1
2020
230
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
Multivariate Analysis
1
2021
591
0.040
Why?
Osteogenesis
1
2022
366
0.040
Why?
Combined Modality Therapy
1
2021
639
0.040
Why?
Maintenance Chemotherapy
1
2019
51
0.040
Why?
Disease Models, Animal
1
2024
1478
0.040
Why?
Apoptosis
1
2024
1119
0.040
Why?
Cell Survival
1
2020
612
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.040
Why?
Reproducibility of Results
1
2021
1229
0.030
Why?
Genome-Wide Association Study
1
2018
186
0.030
Why?
Fibroblast Growth Factors
1
2017
46
0.030
Why?
Information Dissemination
1
2018
84
0.030
Why?
STAT3 Transcription Factor
1
2017
85
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1378
0.030
Why?
Prospective Studies
1
2023
2481
0.030
Why?
Thalidomide
1
2019
377
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Proportional Hazards Models
1
2018
443
0.030
Why?
Kaplan-Meier Estimate
1
2018
483
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Cohort Studies
1
2020
1542
0.030
Why?
Models, Genetic
1
2016
169
0.030
Why?
Antineoplastic Agents
1
2024
1222
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
151
0.030
Why?
Survival Analysis
1
2017
673
0.030
Why?
Stem Cell Transplantation
1
2016
185
0.030
Why?
Dogs
1
2015
180
0.030
Why?
Databases, Genetic
1
2015
83
0.030
Why?
Time Factors
1
2021
2968
0.030
Why?
Sequence Analysis, RNA
1
2015
100
0.030
Why?
Genetic Testing
1
2015
129
0.030
Why?
Longitudinal Studies
1
2016
747
0.030
Why?
Child
1
2023
7248
0.020
Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description